CD1D公司
生物
炎症
系统性红斑狼疮
TLR9型
免疫学
和平号-155
细胞生物学
抗原
小RNA
自然杀伤性T细胞
基因表达
内科学
基因
医学
CD8型
遗传学
疾病
DNA甲基化
作者
Fei Liu,Hongye Fan,Deshan Ren,Guanjun Dong,Erling Hu,Jianjian Ji,Yayi Hou
标识
DOI:10.1002/eji.201445286
摘要
B cells present lipid antigens to CD1d-restricted invariant natural killer T (iNKT) cells to maintain autoimmune tolerance, and this process is disrupted in systemic lupus erythematosus (SLE). Inflammation may inhibit CD1d expression to exacerbate the pathology of lupus. However, how inflammation regulates CD1d expression on B cells is unclear in SLE. In the present study, we showed that the surface expression of CD1d on B cells from SLE mice was decreased and that stimulation of inflammatory responses through TLR9 decreased the membrane and total CD1d levels of CD1d on B cells. Moreover, inflammation-related microRNA-155 (miR-155) negatively correlated with the expression of CD1d in B cells. miR-155 directly targeted the 3'-untranslated region (3'-UTR) of CD1d upon TLR9 activation in both humans and mice. The inhibitory effects of miR-155 on CD1d expression in B cells impaired their antigen-presenting capacity to iNKT cells. In addition, Ets-1, a susceptibility gene of SLE, also directly regulated the expression of the CD1d gene at the transcriptional level. These findings provide new insight into the mechanism underlying decreased CD1d expression on B cells in SLE, suggesting that inhibition of inflammation may increase CD1d expression in B cells to ameliorate SLE via modulating iNKT cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI